-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Compilenewborn
According to an update on the clinical trial database (ClinicalTrials.
In an interview with FierceBiotech, AstraZeneca stated that it had found signs of heart problems in a patient treated with AZD5991
Therefore, AstraZeneca has stopped the treatment of patients in the trial and voluntarily suspended the trial
An AstraZeneca spokesperson pointed out: "It is worth noting that the asymptomatic blood pressure increase has been resolved
Two years ago, Amgen's blood cancer drug AMG 397 was also hindered by cardiac safety issues.
Reference source:
1.
2.